Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Candida albicans clades.

David R Soll1, Claude Pujol

  • 1Department of Biological Sciences, The University of Iowa, Iowa City, IA 52242, USA. david-soll@uiowa.edu

FEMS Immunology and Medical Microbiology
|October 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

White-opaque switching in <i>Candida albicans</i>: cell biology, regulation, and function.

Microbiology and molecular biology reviews : MMBR·2024
Same author

3D and 4D Tumorigenesis Model for the Quantitative Analysis of Cancer Cell Behavior and Screening for Anticancer Drugs.

Methods in molecular biology (Clifton, N.J.)·2021
Same author

Role of the <i>WOR1</i> Promoter of Candida albicans in Opaque Commitment.

mBio·2021
Same author

Directed movement toward, translocation along, penetration into and exit from vascular networks by breast cancer cells in 3D.

Cell adhesion & migration·2021
Same author

New monoclonal antibodies that recognize an unglycosylated, conserved, extracellular region of CD44 in vitro and in vivo, and can block tumorigenesis.

PloS one·2021
Same author

Candida albicans Double Mutants Lacking both <i>EFG1</i> and <i>WOR1</i> Can Still Switch to Opaque.

mSphere·2020
Same journal

Retraction. The role of nitric oxide in inflammatory reactions.

FEMS immunology and medical microbiology·2013
Same journal

Pluronic P85 enhances the efficacy of outer membrane vesicles as a subunit vaccine against Brucella melitensis challenge in mice.

FEMS immunology and medical microbiology·2012
Same journal

Mannose receptor, C type 1 contributes to bacterial uptake by placental trophoblast giant cells.

FEMS immunology and medical microbiology·2012
Same journal

Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.

FEMS immunology and medical microbiology·2012
Same journal

Alcohol treatment enhances Staphylococcus aureus biofilm development.

FEMS immunology and medical microbiology·2012
Same journal

Human intestinal epithelial cell-derived molecule(s) increase enterohemorrhagic Escherichia coli virulence.

FEMS immunology and medical microbiology·2012
See all related articles

DNA fingerprinting identified five distinct Candida albicans clades with specific geographic distributions. These clades show limited recombination between groups, suggesting distinct evolutionary paths and phenotypic differences, impacting pathogenesis research.

Area of Science:

  • Microbiology
  • Population Genetics
  • Medical Mycology

Background:

  • Candida albicans is a significant human pathogen.
  • Understanding the population structure of C. albicans is crucial for effective treatment and control.
  • Previous studies have suggested genetic diversity within C. albicans.

Purpose of the Study:

  • To investigate the population structure of Candida albicans using DNA fingerprinting.
  • To identify distinct clades within C. albicans and their geographical distribution.
  • To explore the implications of clade structure on recombination, phenotypic characteristics, and pathogenesis.

Main Methods:

  • DNA fingerprinting using the complex probe Ca3.
  • Analysis of geographical specificity of identified clades.

Related Experiment Videos

  • Assessment of recombination rates within and between clades.
  • Evaluation of phenotypic characteristics, such as drug resistance.

    • Main Results:

    • Five distinct Candida albicans clades were identified: group I, group II, group III, group SA, and group E.
    • Significant geographical specificity was observed for several clades (e.g., SA in South Africa, E in Europe, II absent in Southwest USA/South America).
    • Evidence suggests limited recombination between clades but higher recombination within clades.
    • Group I isolates showed exclusive 5-fluorocytosine resistance, indicating phenotypic differences between clades.

    Conclusions:

    • Candida albicans exists as distinct, geographically structured clades with limited inter-clade recombination.
    • Phenotypic differences, including drug resistance, exist between clades.
    • The findings challenge the notion of a single representative C. albicans strain and necessitate clade-specific analysis for understanding pathogenesis and developing treatments.